Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
227.5 CHF | +1.29% | +2.34% | -6.95% |
15.05. | Schweizer Aktien legen zu, da kühle US-Inflationsdaten die Stimmung verbessern | MT |
15.05. | Aktien Schweiz von günstigen US-Daten auf Jahreshoch gehievt | DJ |
Kurzporträt
Mitarbeiterzahl: 103 605
Umsatz nach Geschäftsbereich
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4.83% |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20.43% |
Umsatz je Region
CHF in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3.28% |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6.05% |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9.76% |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30.81% |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3.52% |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12.81% |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20.26% |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33.09% |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23.96% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 49 | 01.01.03 | |
Severin Schwan
CHM | Chairman | 57 | 01.01.08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01.04.11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01.01.20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01.01.15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01.04.20 |
General Counsel | 60 | 01.04.20 | |
Human Resources Officer | 57 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03.03.15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01.01.96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17.03.20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05.03.19 |
Severin Schwan
CHM | Chairman | 57 | 01.01.08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14.03.17 |
Director/Board Member | 58 | 01.03.16 | |
Jemilah Mahmood
BRD | Director/Board Member | - | - |
Akiko Iwasaki
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Aktie B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
1 005 670 000 | 59,89% | 32 272 955 970 $ | |
ROCHE HOLDING AG 1,43% | 10 073 029 | 1,43% | 2 422 842 800 $ |
2 744 120 | 8,15% | 33 917 323 $ | |
454 961 | 3,02% | 9 636 074 $ | |
ALIGOS THERAPEUTICS, INC. 15,19% | 11 025 941 | 15,19% | 9 019 220 $ |
1 893 | 0,06% | 1 486 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Viewics India Pvt Ltd.
| |
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The private company is based in Woerden, Netherlands. |
Medical Distributors
|
Roche Diagnostics India Pvt Ltd.
Roche Diagnostics India Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The private company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers. |
Medical Specialties
|
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The private company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-6.95% | 200 Mrd. | |
+31.37% | 588 Mrd. | |
-2.60% | 364 Mrd. | |
+20.83% | 326 Mrd. | |
+5.69% | 285 Mrd. | |
+14.83% | 239 Mrd. | |
+9.93% | 210 Mrd. | |
+10.77% | 167 Mrd. | |
+0.10% | 161 Mrd. | |
+0.89% | 124 Mrd. |
- Börse
- Aktien
- 855167 Aktie
- Unternehmen Roche Holding AG